A Pharmacokinetic Study of Trabectedin in Patients With Advanced Malignancies and Hepatic Dysfunction

Clinical trial NCT01273493 · COMPLETED

Trial details

NCT number: NCT01273493
Sponsor: Janssen Research & Development, LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Neoplasm Metastases Hepatic Insufficiency

Start date: 2010-12-01
Primary completion: 2014-04-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.